Virtus Lifesci Biotech Etf Current Valuation
| BBP Etf | USD 52.96 0.49 0.92% |
Valuation analysis of Virtus LifeSci Biotech helps investors to measure Virtus LifeSci's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Virtus LifeSci's price fluctuation is very steady at this time. Calculation of the real value of Virtus LifeSci Biotech is based on 3 months time horizon. Increasing Virtus LifeSci's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Virtus LifeSci Biotech is useful when determining the fair value of the Virtus etf, which is usually determined by what a typical buyer is willing to pay for full or partial control of Virtus LifeSci. Since Virtus LifeSci is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Virtus Etf. However, Virtus LifeSci's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 52.96 | Real 49.54 | Hype 52.96 | Naive 52.96 |
The real value of Virtus Etf, also known as its intrinsic value, is the underlying worth of Virtus LifeSci Biotech ETF, which is reflected in its stock price. It is based on Virtus LifeSci's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Virtus LifeSci's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Virtus LifeSci's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Virtus LifeSci Biotech helps investors to forecast how Virtus etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Virtus LifeSci more accurately as focusing exclusively on Virtus LifeSci's fundamentals will not take into account other important factors: Virtus LifeSci Biotech ETF Current Valuation Analysis
Virtus LifeSci's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Virtus LifeSci Biotech has a Current Valuation of 0.0. This indicator is about the same for the Virtus average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Fund Asset Allocation for Virtus LifeSci
The fund consists of 98.73% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides Virtus LifeSci's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Virtus Fundamentals
| Price To Earning | 18.03 X | |||
| Price To Book | 1.66 X | |||
| Price To Sales | 5.60 X | |||
| Number Of Employees | 12 | |||
| Beta | 0.65 | |||
| Total Asset | 15.87 M | |||
| One Year Return | 2.90 % | |||
| Three Year Return | (1.50) % | |||
| Five Year Return | 4.10 % | |||
| Net Asset | 15.87 M | |||
| Equity Positions Weight | 98.73 % |
About Virtus LifeSci Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virtus LifeSci Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virtus LifeSci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virtus LifeSci Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Virtus LifeSci in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Virtus LifeSci's short interest history, or implied volatility extrapolated from Virtus LifeSci options trading.
Pair Trading with Virtus LifeSci
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virtus LifeSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will appreciate offsetting losses from the drop in the long position's value.Moving together with Virtus Etf
| 0.61 | VHT | Vanguard Health Care | PairCorr |
| 0.79 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.71 | XBI | SPDR SP Biotech | PairCorr |
Moving against Virtus Etf
| 0.77 | XOP | SPDR SP Oil | PairCorr |
| 0.74 | XES | SPDR SP Oil | PairCorr |
The ability to find closely correlated positions to Virtus LifeSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virtus LifeSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virtus LifeSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virtus LifeSci Biotech to buy it.
The correlation of Virtus LifeSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virtus LifeSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virtus LifeSci Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virtus LifeSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Virtus LifeSci Piotroski F Score and Virtus LifeSci Altman Z Score analysis. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.